// App-Quantinova.ai

P1-05-27 : Evaluation of the Oncomine focus and comprehensive assays for therapeutic stratification in early hormone receptor positive breast cancers

Researchers

Presenter

  • J Bayani

Principal Investigators

  • C Crozier

  • NX Zhang

  • Y Amemiya

  • MA Quintayo

  • FJ Yan

  • D Dion

  • S Mccormack

  • M Yaffe

  • A Seth

  • H Feilotter

  • JMS Bartlett

Medical Centers

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Queen's University, Kingston, ON, CA

  • University of Toronto, Toronto, ON, Canada

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Alpha thalassemia mental retardation X-linked protein

  • cMYC

  • Cyclin D1

  • Cyclin Dependent Kinase Inhibitor 2A

  • Retinoblastoma protein

  • erb-b2 receptor tyrosine kinase 2

  • Fibroblast growth factor receptor 1

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved